Amneal Acquires India’s Puniska To Double Injectables Business

As Company Looks To Enter US Biosimilars Market In 2022

 
• By Akriti Seth
  
Business Graph
Amneal reports growth in its generics and specialty segment • Source: Alamy
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Generics

More from Products